HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early development of hyponatremia implicates short- and long-term outcomes in ST-elevation acute myocardial infarction.

AbstractBACKGROUND:
Clinical importance of hyponatremia in ST-elevation acute myocardial infarction (STEMI) in the era of primary intervention has not been fully understood. The aim of this study was to investigate the impact of hyponatremia on outcomes in patients with STEMI and secondarily to investigate the contribution of arginine vasopressin (AVP) to hyponatremia in STEMI.
METHODS AND RESULTS:
Hyponatremia was defined as a sodium concentration <136 mmol/L at 72h after hospitalization. First, the short-term (in-hospital mortality or congestive heart failure (CHF)) and long-term prognosis (cardiac death, re-admission for CHF) in STEMI patients was conducted. Second, the relationship between serum sodium level and plasma AVP was investigated. In hyponatremic patients the incidence of in-hospital heart failure was significantly greater (P=0.0018), long-term cardiac death was a higher trend (17.2% vs. 6.3%, P=0.19) and re-admission due to CHF was significantly more frequent (20.7% vs. 4.5%, P=0.0024). Plasma AVP level was higher in the hyponatremia group (4.5 vs. 2.7 pg/ml, P=0.003), and it had a negative correlation with serum sodium level (r=-0.28, P=0.02).
CONCLUSIONS:
Hyponatremia was frequently found in the early phase of STEMI, and associated with heart failure in both short- and long-term outcomes. Non-osmotic secretion of AVP could be involved in hyponatremia in STEMI patients.
AuthorsYuko Tada, Tomohiro Nakamura, Hiroshi Funayama, Yoshitaka Sugawara, Junya Ako, San-E Ishikawa, Shin-Ichi Momomura
JournalCirculation journal : official journal of the Japanese Circulation Society (Circ J) Vol. 75 Issue 8 Pg. 1927-33 ( 2011) ISSN: 1347-4820 [Electronic] Japan
PMID21617327 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Arginine Vasopressin
  • Sodium
Topics
  • Aged
  • Aged, 80 and over
  • Arginine Vasopressin (blood)
  • Female
  • Heart Failure (blood, etiology, mortality)
  • Humans
  • Hyponatremia (blood, complications, mortality)
  • Incidence
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, complications, mortality)
  • Sodium (blood)
  • Survival Rate
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: